Feed PAVM
PA

PAVmed Inc.

PAVM · NASDAQ

$4.18 -2.51% (-$0.11)
1M -22.16%
Market Cap $25.3M
P/E Ratio -
Div. Yield -
ROE 33.51%

Bulios Fair Price

$5.07

21.2% upside

Current Price

$4.18

Undervalued Fair Value Overvalued

According to Bulios Fair Price, PAVM is currently undervalued relative to its market price. How does it work?

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Piotroski F-Score Weak
2/9
Valuation
50 /100
Fair
P/B 0.72x
P/S 226.26x
EV/FFO N/A
Growth
0 /100
Declining
Rev. growth 42.68%
Book val. growth N/A
EPS growth N/A
Profitability
0 /100
Weak
Op. margin 23,842.90%
Gross margin 254.46%
FCF margin 2,343,880.00%
Quality
0 /100
Poor
ROA 30.06%
ROIC 72.77%
Asset turnover 0.00x
Debt
50 /100
Moderate
Int. coverage -958.56x
Debt/Equity 0.49x
Current ratio 1.19x
Stability
27 /100
Unstable
EPS volatility 125.73%
Beta 0.54x
Profitable years 2

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about PAVM
Online

About the company

PAVmed Inc. (PAVM) is an American company focused on innovation in the field of healthcare technologies. The company specializes in the development and commercialization of medical devices and technologies with the potential to improve diagnostics and treatment of various medical conditions. PAVmed focuses on creating patented products and technologies that have the potential to transform the way certain medical procedures are performed. With its innovative approach, PAVmed can attract investors seeking opportunities in healthcare innovation and advanced medical technologies. Shares of PAVmed Inc. (PAVM) could present an intriguing investment opportunity.

Sector

Healthcare

Industry

Medical - Devices

CEO

Lishan Aklog

Employees

41

Headquarters

New York City

Upcoming events

12 NOV

Earnings

Upcoming earnings report

50d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.